Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018497 |
---|---|
Receipt number | R000021402 |
Scientific Title | Prospective study of I-131 3-iodobenzylguanidine radiotherapy for refractory pheochromocytoma; in accordance with the Japanese Advanced Medical Care B program for the anticancer drug with high medical needs. |
Date of disclosure of the study information | 2015/07/31 |
Last modified on | 2020/02/13 13:47:16 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/07/30 19:22:13 | ||
2 | Update | 2015/07/31 13:06:55 | UMIN ID1 |
|
3 | Update | 2015/08/04 12:44:41 | UMIN ID2 |
|
4 | Update | 2015/08/04 14:18:23 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria |
|
5 | Update | 2015/08/07 11:30:09 | Interventions/Control_1 |
|
6 | Update | 2015/08/25 13:56:16 | Public title Public title Acronym Acronym |
|
7 | Update | 2015/08/25 13:59:09 | Condition Narrative objectives1 Narrative objectives1 |
|
8 | Update | 2015/08/25 14:10:53 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
9 | Update | 2015/08/25 14:14:01 | Condition |
|
10 | Update | 2015/12/07 21:11:02 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
11 | Update | 2016/02/15 18:23:08 | Recruitment status |
|
12 | Update | 2016/04/03 20:40:36 | Name of primary person or sponsor Institute Organization Organization Institutions |
|
13 | Update | 2016/06/04 18:03:56 | Institutions |
|
14 | Update | 2017/03/29 16:39:04 | Name of person sending information Name of person sending information Organization Organization Division name Division name |
|
15 | Update | 2018/07/23 07:31:23 | Recruitment status |
|
16 | Update | 2019/04/24 17:48:39 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
17 | Update | 2019/04/24 17:50:09 | Date of IRB |
|
18 | Update | 2019/05/20 14:56:06 | Recruitment status Other related information |
|
19 | Update | 2020/02/13 12:41:26 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
20 | Update | 2020/02/13 13:47:16 | Recruitment status |